OPTI-AML: Prospective Comparison of 28 vs.14 days of Venetoclax Induction with Azacitidine in Older Adults with AML

Uma M Borate, Ying Huang, Tara L. Lin, Shivani Handa, Ronan Swords, Curtis A. Lachowiez, Elie Traer, Wendy Stock, Olatoyosi Odenike, Anand A Patel, Maria R Baer, Vu H. Duong, Eytan M. Stein, William Blum, Colin Anthony Vale, Emily Curran, Yazan F. Madanat, Rebecca L. Olin, Gary J. Schiller, Angela D Nichols, Lacey Williams, Nyla A. Heerema, Mary F Johnson, Timothy L Chen, Sonja Marcus, Molly Martycz, Mona Stefanos, Leonard Rosenberg, Louis James DeGennaro, Lore Gruenbaum, Amy Burd, John C Byrd, Brian J. Druker, Ross L Levine, Ashley O Yocum, Alice S. Mims, Joshua F Zeidner

Open source

DOI: 10.1182/blood.2026034611
Published: 2026-07-28
Container: Blood Journal
Publisher: American Society of Hematology
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood.2026034611,
  title = {OPTI-AML: Prospective Comparison of 28 vs.14 days of Venetoclax Induction with Azacitidine in Older Adults with AML},
  author = {Uma M Borate and Ying Huang and Tara L. Lin and Shivani Handa and Ronan Swords and Curtis A. Lachowiez and Elie Traer and Wendy Stock and Olatoyosi Odenike and Anand A Patel and Maria R Baer and Vu H. Duong and Eytan M. Stein and William Blum and Colin Anthony Vale and Emily Curran and Yazan F. Madanat and Rebecca L. Olin and Gary J. Schiller and Angela D Nichols and Lacey Williams and Nyla A. Heerema and Mary F Johnson and Timothy L Chen and Sonja Marcus and Molly Martycz and Mona Stefanos and Leonard Rosenberg and Louis James DeGennaro and Lore Gruenbaum and Amy Burd and John C Byrd and Brian J. Druker and Ross L Levine and Ashley O Yocum and Alice S. Mims and Joshua F Zeidner},
  year = {2026},
  journal = {Blood Journal},
  doi = {10.1182/blood.2026034611},
  url = {https://doi.org/10.1182/blood.2026034611}
}

RIS

TY  - JOUR
TI  - OPTI-AML: Prospective Comparison of 28 vs.14 days of Venetoclax Induction with Azacitidine in Older Adults with AML
AU  - Uma M Borate
AU  - Ying Huang
AU  - Tara L. Lin
AU  - Shivani Handa
AU  - Ronan Swords
AU  - Curtis A. Lachowiez
AU  - Elie Traer
AU  - Wendy Stock
AU  - Olatoyosi Odenike
AU  - Anand A Patel
AU  - Maria R Baer
AU  - Vu H. Duong
AU  - Eytan M. Stein
AU  - William Blum
AU  - Colin Anthony Vale
AU  - Emily Curran
AU  - Yazan F. Madanat
AU  - Rebecca L. Olin
AU  - Gary J. Schiller
AU  - Angela D Nichols
AU  - Lacey Williams
AU  - Nyla A. Heerema
AU  - Mary F Johnson
AU  - Timothy L Chen
AU  - Sonja Marcus
AU  - Molly Martycz
AU  - Mona Stefanos
AU  - Leonard Rosenberg
AU  - Louis James DeGennaro
AU  - Lore Gruenbaum
AU  - Amy Burd
AU  - John C Byrd
AU  - Brian J. Druker
AU  - Ross L Levine
AU  - Ashley O Yocum
AU  - Alice S. Mims
AU  - Joshua F Zeidner
PY  - 2026
JO  - Blood Journal
DO  - 10.1182/blood.2026034611
UR  - https://doi.org/10.1182/blood.2026034611
ER  -

APA

Borate, U. M., Huang, Y., Lin, T. L., Handa, S., Swords, R., Lachowiez, C. A., Traer, E., Stock, W., Odenike, O., Patel, A. A., Baer, M. R., Duong, V. H., Stein, E. M., Blum, W., Vale, C. A., Curran, E., Madanat, Y. F., Olin, R. L., Schiller, G. J., Nichols, A. D., Williams, L., Heerema, N. A., Johnson, M. F., Chen, T. L., Marcus, S., Martycz, M., Stefanos, M., Rosenberg, L., DeGennaro, L. J., Gruenbaum, L., Burd, A., Byrd, J. C., Druker, B. J., Levine, R. L., Yocum, A. O., Mims, A. S., & Zeidner, J. F. (2026). OPTI-AML: Prospective Comparison of 28 vs.14 days of Venetoclax Induction with Azacitidine in Older Adults with AML. Blood Journal. https://doi.org/10.1182/blood.2026034611

Source records

crossref · retrieved 2026-09-26T01:22:43.958Z